ANJIX
Price
$29.20
Change
+$0.08 (+0.27%)
Updated
Aug 12 closing price
Net Assets
86.25M
VTSNX
Price
$187.75
Change
+$1.32 (+0.71%)
Updated
Aug 12 closing price
Net Assets
645.82B
Interact to see
Advertisement

ANJIX vs VTSNX

ANJIX vs VTSNX Comparison Chart in %
View a ticker or compare two or three
VS
ANJIX vs. VTSNX commentary
Aug 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANJIX is a StrongBuy and VTSNX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 646B vs. ANJIX (86.2M). ANJIX pays higher dividends than VTSNX: ANJIX (5.08) vs VTSNX (2.58). ANJIX was incepted earlier than VTSNX: ANJIX (24 years) vs VTSNX (16 years). ANJIX (1.13) is less costly to investors than VTSNX (0.06). ANJIX is a more actively managed with annual turnover of: 56.00 vs. VTSNX (4.00). ANJIX has a lower initial minimum investment than VTSNX: ANJIX (1000000) vs VTSNX (5000000). ANJIX annual gain was more profitable for investors over the last year : 30.94 vs. VTSNX (23.44). ANJIX return over 5 years is better than : 47.23 vs. VTSNX (37.79).
ANJIXVTSNXANJIX / VTSNX
Total Expense Ratio0.950.061,583%
Annual Report Gross Expense Ratio1.130.061,883%
Fund Existence24 years16 years-
Gain YTD18.46415.278121%
Front LoadN/AN/A-
Min. Initial Investment1000000500000020%
Min. Initial Investment IRAN/AN/A-
Net Assets86.2M646B0%
Annual Yield % from dividends5.082.58197%
Returns for 1 year30.9423.44132%
Returns for 3 years63.5059.08107%
Returns for 5 years47.2337.79125%
Returns for 10 years112.0498.91113%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CFIAX16.380.12
+0.74%
Columbia Flexible Capital Income A
MECDX17.130.04
+0.23%
NYLI Epoch Capital Growth Class A
AMCFX47.44N/A
N/A
American Funds AMCAP F-2
AYBLX14.70N/A
N/A
Victory Pioneer Balanced Y
PZVEX17.31N/A
N/A
Pzena Emerging Markets Value Investor